Adaptimmune Therapeutics (ADAP) News Today → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free ADAP Stock Alerts $1.08 +0.02 (+1.42%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAdaptimmune: Huge Opportunity Amid Their Setback With Genentechseekingalpha.com - April 26 at 12:45 PMGenentech parent Roche has cut 20% of risky drugs from pipeline and is adjusting its workforce to matchbizjournals.com - April 26 at 2:44 AMAdaptimmune Therapeutics (NASDAQ:ADAP) Shares Gap Up to $1.01americanbankingnews.com - April 25 at 5:50 AMAdaptimmune Therapeutics (NASDAQ:ADAP) Shares Down 5.3% marketbeat.com - April 24 at 3:36 PMAdaptimmune Therapeutics Plc - ADRmoney.usnews.com - April 24 at 10:31 AMGarry Menzel joins GHO Capital as Operating Partnerfinance.yahoo.com - April 24 at 12:23 AMAdaptimmune Therapeutics (NASDAQ:ADAP) Stock Price Up 12.4%americanbankingnews.com - April 21 at 2:32 AMEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Downmsn.com - April 19 at 12:46 PMAdaptimmune Therapeutics (NASDAQ:ADAP) Shares Up 12.4%marketbeat.com - April 19 at 11:58 AMAdaptimmune Therapeutics (NASDAQ:ADAP) Shares Down 4.8% marketbeat.com - April 16 at 2:02 PMMaintaining Buy Rating on Adaptimmune Therapeutics Post-Genentech Collaboration Terminationmarkets.businessinsider.com - April 16 at 10:28 AMAdaptimmune shares drop as Genentech terminates potential $3B dealbizjournals.com - April 12 at 3:49 PMAdaptimmune falls as Roche strategic collaboration endsmsn.com - April 12 at 10:49 AMAdaptimmune Therapeutics (NASDAQ:ADAP) Shares Up 3.9%marketbeat.com - April 11 at 2:49 PMBaillie Gifford & Co. Sells 1,235,269 Shares of Adaptimmune Therapeutics plc (NASDAQ:ADAP)marketbeat.com - April 11 at 7:24 AMAdaptimmune Therapeutics (NASDAQ:ADAP) Shares Down 3.8% marketbeat.com - April 1 at 2:58 PMShort Interest in Adaptimmune Therapeutics plc (NASDAQ:ADAP) Expands By 11.1%marketbeat.com - April 1 at 1:39 AMAdaptimmune Therapeutics (NASDAQ:ADAP) Trading Down 2.1%marketbeat.com - March 26 at 1:01 PMAnalysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE) and AbbVie (ABBV)markets.businessinsider.com - March 26 at 2:24 AMAdaptimmune Therapeutics (NASDAQ:ADAP) Trading 4.5% Higher marketbeat.com - March 22 at 2:31 PMAnalysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and Viridian Therapeutics (VRDN)markets.businessinsider.com - March 21 at 5:29 PMAdaptimmune Therapeutics (NASDAQ:ADAP) Shares Gap Down to $1.33marketbeat.com - March 21 at 3:51 PMAdaptimmune Therapeutics (NASDAQ:ADAP) Shares Down 6.1% marketbeat.com - March 18 at 11:55 AMPeter W. Sonsini's Net Worthbenzinga.com - March 15 at 1:22 PMADAP Sep 2024 2.500 putfinance.yahoo.com - March 15 at 1:22 PMAdaptimmune Therapeutics (NASDAQ:ADAP) Shares Gap Down to $1.59marketbeat.com - March 14 at 11:56 AMEuropean Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Tradingmsn.com - March 13 at 12:42 PMAdaptimmune Therapeutics (NASDAQ:ADAP) Shares Gap Up to $1.49marketbeat.com - March 13 at 12:33 PMAnalysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Adaptimmune Therapeutics (ADAP) and Arcutis Biotherapeutics (ARQT)markets.businessinsider.com - March 13 at 7:41 AMAdaptimmune Therapeutics (NASDAQ:ADAP) Trading Down 4%marketbeat.com - March 11 at 11:53 AMAdaptimmune Therapeutics (NASDAQ:ADAP) Sees Unusually-High Trading Volumemarketbeat.com - March 8 at 12:00 PMAdaptimmune Therapeutics plc (ADAP) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 8 at 7:56 AMBuy Rating Affirmed for Adaptimmune on Strong Clinical Results and Commercial Strategymarkets.businessinsider.com - March 8 at 7:56 AMAdaptimmune Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - March 8 at 7:56 AMBrokers Issue Forecasts for Adaptimmune Therapeutics plc's Q1 2024 Earnings (NASDAQ:ADAP)marketbeat.com - March 8 at 6:35 AMAdaptimmune Therapeutics Earnings Previewbenzinga.com - March 7 at 9:12 PMBuy Rating Affirmed for Adaptimmune on Upcoming Milestones and Promising Trial Resultsmarkets.businessinsider.com - March 7 at 9:12 PMAdaptimmune Therapeutics PLC Reports Q4 and Full Year 2023 Financial Resultsfinance.yahoo.com - March 7 at 4:12 PMAdaptimmune Therapeutics (NASDAQ:ADAP) Hits New 12-Month High at $1.85marketbeat.com - March 7 at 10:51 AMAdaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 7 at 10:26 AMADAP Stock Earnings: Adaptimmune Therapeutics Misses EPS, Misses Revenue for Q4 2023investorplace.com - March 6 at 2:00 PMAdaptimmune Therapeutics earnings: here's what Wall Street expectsmarkets.businessinsider.com - March 5 at 10:47 AMAdaptimmune Therapeutics (ADAP) to Release Quarterly Earnings on Wednesdaymarketbeat.com - March 5 at 7:41 AMBuy Rating Affirmed for Adaptimmune Following Reappointment of Key Executive and Strategic Commercialization Planmarkets.businessinsider.com - March 1 at 12:04 PMAdaptimmune reappoints Cintia Piccina as chief commercial officerinvesting.com - February 29 at 10:08 AMADAP Apr 2024 1.500 putfinance.yahoo.com - February 28 at 4:07 AMAdaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchisefinance.yahoo.com - February 27 at 12:15 PMADAP Apr 2024 2.000 callfinance.yahoo.com - February 26 at 1:41 AMAdaptimmune Therapeutics PLC ADRwsj.com - February 24 at 5:50 PMADAP Sep 2024 2.000 callfinance.yahoo.com - February 23 at 11:02 AM Get Adaptimmune Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAP and its competitors with MarketBeat's FREE daily newsletter. Email Address His win rate puts Warren Buffett to shame… (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss. Click here now for the full story. ADAP Media Mentions By Week ADAP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADAP News Sentiment▼0.180.34▲Average Medical News Sentiment ADAP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADAP Articles This Week▼72▲ADAP Articles Average Week Get Adaptimmune Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KYTX News SRRK News BCRX News VIR News RLAY News IMTX News RGNX News TARS News CRGX News CABA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADAP) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptimmune Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
